Company Description
Rafael Holdings, Inc. owns interest in commercial real estate assets and clinical stage pharmaceutical companies. It operates through the Real Estate and Pharmaceuticals segments. The Real Estate segment refers to the real estate holdings. The Pharmaceuticals segment is comprised of debt interests a...
Rafael Holdings, Inc. owns interest in commercial real estate assets and clinical stage pharmaceutical companies. It operates through the Real Estate and Pharmaceuticals segments. The Real Estate segment refers to the real estate holdings. The Pharmaceuticals segment is comprised of debt interests and warrants in Rafael Pharmaceuticals and a majority equity interest in LipoMedix Pharmaceuticals. The company was founded in 2017 and is headquartered in Newark, NJ.
Valuation
Price to Sales Ratio
97.39
Price to Book Ratio
0.49
Enterprise Value to EBITDA
0.15
Enterprise Value to Sales
-8.17
Total Debt to Enterprise Value
-1.29
Efficiency
Revenue/Employee
17,826.00
Income Per Employee
-5,340,348.00
Receivables Turnover
0.66
Total Asset Turnover
0.00
Liquidity
Current Ratio
5.15
Quick Ratio
5.15
Cash Ratio
3.01
Profitability
Gross Margin
82.44
Operating Margin
-14,750.49
Pretax Margin
-34,139.51
Net Margin
-29,958.05
Return on Assets
-90.19
Return on Equity
-110.26
Return on Total Capital
-45.91
Return on Invested Capital
-110.26
Capital Structure
Total Debt to Total Equity
14.92
Total Debt to Total Capital
12.99
Total Debt to Total Assets
12.68
Officers and Executives
Name | Age | Officer Since | Title |
---|---|---|---|
Mr. Howard S. Jonas | 64 | 2017 | Chairman & Chief Executive Officer |
Mr. William Conkling | - | 2021 | Chief Commercial Officer |
Mr. David A. Polinsky | 50 | 2017 | Chief of Staff |
Mr. Gus Kodersha | - | 2021 | Chief Technical Operations Officer |
Ms. Rachel Jonas | - | 2021 | Director |
Insider Actions
01/05/2023 |
Stephen M. Greenberg Director |
27,174 | Award at $1.84 per share. | 50,000 |
01/05/2023 |
Michael J. Weiss Director |
27,174 | Award at $1.84 per share. | 50,000 |
01/05/2023 |
Boris C. Pasche Director |
27,174 | Award at $1.84 per share. | 50,000 |
01/05/2023 |
Mark A. McCamish Director |
27,174 | Award at $1.84 per share. | 50,000 |
12/21/2022 |
William Conkling Chief Executive Officer |
56,149 | Derivative/Non-derivative trans. at $1.76 per share. | 98,822 |
12/21/2022 |
Patrick Fabbio CFO & President |
27,928 | Derivative/Non-derivative trans. at $1.76 per share. | 49,153 |
08/09/2022 |
Howard S. Jonas |
64,674 | Disposition at $1.84 per share. | 119,000 |
08/08/2022 |
Howard S. Jonas |
14,787 | Disposition at $1.94 per share. | 28,686 |
08/05/2022 |
Howard S. Jonas |
33,100 | Disposition at $1.93 per share. | 63,883 |
02/01/2022 |
William Conkling Chief Executive Officer |
623,732 | Award at $0 per share. | 0 |
02/01/2022 |
Patrick Fabbio CFO & President |
363,103 | Award at $0 per share. | 0 |
02/01/2022 |
Ameet Mallik Director |
908,497 | 0 | |
01/19/2022 |
Stephen M. Greenberg Director |
7,512 | Award at $5.39 per share. | 40,489 |
01/05/2022 |
Boris C. Pasche Director |
7,512 | Award at $5.39 per share. | 40,489 |
01/05/2022 |
Mark A. McCamish Director |
5,412 | Award at $5.39 per share. | 29,170 |
01/05/2022 |
Shannon Thyme Klinger Director |
5,412 | Award at $5.39 per share. | 29,170 |
09/23/2021 |
David A. Polinsky Chief Financial Officer |
571 | Derivative/Non-derivative trans. at $35.77 per share. | 20,424 |
05/27/2021 |
Ameet Mallik Director |
908,497 | Award at $44.7 per share. | 40,609,815 |
MarketWatch News on RFL
Other News on RFL
-
- Edgar Online - (EDG = 10Q, 10K)
-
- Edgar Online - (EDG = 10Q, 10K)
-
- Edgar Online - (EDG = 10Q, 10K)
-
Tracking Kahn Brothers Portfolio - Q2 2022 Update
- Seeking Alpha
-
- Edgar Online - (EDG = 10Q, 10K)
-
Tracking Kahn Brothers Portfolio - Q1 2022 Update
- Seeking Alpha
-
Tracking Kahn Brothers Portfolio - Q4 2021 Update
- Seeking Alpha
-
Rafael announces CEO transition
- Seeking Alpha
-
In a Bad Year for Biotech Stocks, Deals and Vaccines Were Winners
- The Wall Street Journal Interactive Edition
-
- Seeking Alpha
-
Tracking Kahn Brothers Portfolio - Q3 2021 Update
- Seeking Alpha
- Loading more headlines...